AR013165A1 - Composiciones farmaceuticas que contienen eletriptan hemisulfato - Google Patents

Composiciones farmaceuticas que contienen eletriptan hemisulfato

Info

Publication number
AR013165A1
AR013165A1 ARP980103209A ARP980103209A AR013165A1 AR 013165 A1 AR013165 A1 AR 013165A1 AR P980103209 A ARP980103209 A AR P980103209A AR P980103209 A ARP980103209 A AR P980103209A AR 013165 A1 AR013165 A1 AR 013165A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
compositions containing
eletriptan hemisulphate
containing eletriptan
hemisulphate
Prior art date
Application number
ARP980103209A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR013165A1 publication Critical patent/AR013165A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Packaging Of Annular Or Rod-Shaped Articles, Wearing Apparel, Cassettes, Or The Like (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invencion proporciona una composicion farmacéutica acuosa que comprende de 5 a 200 mg/ml de eletriptán hemisulfato y del 0,5 a 2,0%en peso/volumen de cafeína.
ARP980103209A 1997-07-03 1998-07-01 Composiciones farmaceuticas que contienen eletriptan hemisulfato AR013165A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714081.8A GB9714081D0 (en) 1997-07-03 1997-07-03 Pharmaceutical compositions
GBGB9718270.3A GB9718270D0 (en) 1997-07-03 1997-08-28 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
AR013165A1 true AR013165A1 (es) 2000-12-13

Family

ID=10815339

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980103209A AR013165A1 (es) 1997-07-03 1998-07-01 Composiciones farmaceuticas que contienen eletriptan hemisulfato

Country Status (13)

Country Link
KR (1) KR100384346B1 (es)
AP (1) AP1100A (es)
AR (1) AR013165A1 (es)
CO (1) CO4950555A1 (es)
GB (2) GB9714081D0 (es)
GT (1) GT199800105A (es)
HN (1) HN1998000101A (es)
MY (1) MY119643A (es)
PA (1) PA8454501A1 (es)
PE (1) PE84499A1 (es)
TN (1) TNSN98126A1 (es)
UA (1) UA49955C2 (es)
ZA (1) ZA985812B (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
AP1100A (en) 2002-09-02
GB9714081D0 (en) 1997-09-10
PE84499A1 (es) 1999-09-11
ZA985812B (en) 2000-01-10
GB9718270D0 (en) 1997-11-05
CO4950555A1 (es) 2000-09-01
MY119643A (en) 2005-06-30
KR20010014366A (ko) 2001-02-26
UA49955C2 (uk) 2002-10-15
PA8454501A1 (es) 2000-05-24
KR100384346B1 (ko) 2003-05-16
HN1998000101A (es) 1999-01-08
GT199800105A (es) 2000-01-04
AP9801290A0 (en) 1998-09-30
TNSN98126A1 (fr) 2005-03-15

Similar Documents

Publication Publication Date Title
ES2163291T3 (es) Composiciones farmaceuticas que contienen eletriptan hemisulfato y cafeina.
ES2181055T3 (es) Formulaciones galenicas que contienen antagonistas de opiaceos.
CO4940450A1 (es) Formulaciones farmaceuticas que contienen voriconazol
AR015379A1 (es) Ascorbil-fosforil-colesterol
HN1998000086A (es) Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
ES2184293T3 (es) Composiciones farmaceuticas administrables por via oral que comprenden una benzhidrilpiperazina y una ciclodextrina.
ES2181501T3 (es) Composicion cosmetica.
ES2186887T3 (es) Comprimidos que contienen una mezcla adulcorante.
CO4770947A1 (es) Composiciones antimicrobianas que contienen alcohol c3-c6
HN1998000045A (es) Composiciones farmaceuticas
ES2191625T3 (es) Composicion oral que contiene perlita.
AR013165A1 (es) Composiciones farmaceuticas que contienen eletriptan hemisulfato
ECSP982578A (es) Composiciones farmaceuticas que contienen eletriptan hemisulfato
HN2000000057A (es) Derivados de i - trifluorometil-4-hidroxi-7-piperidinil- aminometilcromano.
MD1473G2 (ro) Remediu antiherpetic
ES2149736T1 (es) Composiciones farmaceuticas conteniendo derivados de tienopiridina estables y libres de antioxidantes.
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
BR9907195A (pt) " formulações de tiagabina de liberação prolongada com efeitos colaterais reduzidos "
AR023056A1 (es) Composiciones farmaceuticas basadas en alfa-ciclodextrina para la administracion por via oral de analogos de lh-rh
ES2175086T3 (es) Composiciones farmaceuticas anti-emeticas que contienen metotrimeprazina.
GT199800086A (es) Formulaciones farmaceuticas que contienen voriconazol.
ATE266412T1 (de) Pharmazeutische zubereitung enthaltend dithranol
ECSP982538A (es) Formulaciones farmaceuticas que contienen variconazol
HN1998000056A (es) Agente farmaceutico
BG97912U (en) Means for mouth flavour and disinfestation

Legal Events

Date Code Title Description
FB Suspension of granting procedure